MRI at 7 Tesla and above: Demonstrated and potential capabilities

Journal of Magnetic Resonance Imaging

Volumn 41, Issue 1, 2015, Pages 13-33

  Kraff, Oliver ^a   Fischer, Anja ^a   Nagel, Armin M ^b   Mönninghoff, Christoph ^a   Ladd, Mark E ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Clinical; Neuro applications; Technical demands; Ultra high field imaging; Whole body; X nuclei applications

Indexed keywords

CHLORINE; LITHIUM; OXYGEN 17; PHOSPHORUS 31; POTASSIUM 39; POTASSIUM ION; SODIUM 23; UNCLASSIFIED DRUG;

BRAIN; BRAIN TUMOR; CARDIAC IMAGING; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; JOINT; MAGNET; MAGNETIC FIELD; MAGNETIC RESONANCE ANGIOGRAPHY; MAMMOGRAPHY; MUSCULOSKELETAL SYSTEM; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIMARY TUMOR; REVIEW; SPINE RADIOGRAPHY; WHOLE BODY IMAGING; HUMAN; MAGNETISM; PROCEDURES;

HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETICS; WHOLE BODY IMAGING;

EID: 84919351219     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24573     Document Type: Review

References (173)

1. Ocali O, Atalar E. Ultimate intrinsic signal-to-noise ratio in MRI. Magn Reson Med 1998;39:462-473.
2. Blamire AM. The technology of MRI-the next 10 years? Br J Radiol 2008;81:601-617.
3. Alvarez-Linera J. 3T MRI: advances in brain imaging. Eur J Radiol 2008;67:415-426.
4. Lee VS, Hecht EM, Taouli B, Chen Q, Prince K, Oesingmann N. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007; 244:692-705.
5. International Electrotechnical Commission. Medical electrical equipment - Part 2-33: particular requirements for the safety of magnetic resonance diagnostic devices. IEC 60601-2-33. 3.0 ed; 2010.
6. Robitaille PM, Abduljalil AM, Kangarlu A. Ultra high resolution imaging of the human head at 8 tesla: 2K x 2K for Y2K. J Comput Assist Tomogr 2000;24:2-8.
7. Vaughan JT, Garwood M, Collins CM, et al. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 2001;46:24-30.
8. Norris DG. High field human imaging. J Magn Reson Imaging 2003;18:519-529.
9. Moser E, Stahlberg F, Ladd ME, Trattnig S. 7-T MR-from research to clinical applications? NMR Biomed 2012;25:695-716.
10. van der Kolk AG, Hendrikse J, Zwanenburg JJ, Visser F, Luijten PR. Clinical applications of 7 T MRI in the brain. Eur J Radiol 2013;82:708-718.
11. United States Food and Drug Administration. Guidance for industry and FDA staff: criteria for significant risk investigations of magnetic resonance diagnostic devices. 2003. Available at: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm072688.pdf. Accessed November 26, 2013.
12. Regatte RR, Schweitzer ME. Ultra-high-field MRI of the musculoskeletal system at 7.0T. J Magn Reson Imaging 2007;25:262-269.
13. Ugurbil K. The road to functional imaging and ultrahigh fields. Neuroimage 2012;62:726-735.
14. Bernstein MA, Huston J III, Ward HA. Imaging artifacts at 3.0T. J Magn Reson Imaging 2006;24:735-746.
15. Siemens AG Healthcare Sector, Magnetic Resonance. MAGNETOM 7T: technical details. Available at: http://www.healthcare. siemens.de/magnetic-resonance-imaging/7t-mri-scanner/magnetom- 7t/technical-details. Accessed November 26, 2013.
16. Siemens AG Healthcare Sector, Magnetic Resonance. System owner manual 7T: technical data. 2008. Print No. MR- 02000.629.02.01.02, p 1-20.
17. Magnex Scientific. Cryostat Data. 2006. p 13.
18. National Institutes of Health. Delivery of liquid helium, liquid nitrogen and helium gas. Volume 2013: Federal Business Opportunities (FedBizzOpps.gov). Available at: https://www.fbo.gov/index?s=opportunity&mode=;form&id=35b0dc990 d832d8bb2e4644670bcdef2. Accessed November 26, 2013.
19. Van de Moortele PF, Akgun C, Adriany G, et al. B(1) destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil. Magn Reson Med 2005;54:1503-1518.
20. Collins CM, Liu W, Schreiber W, Yang QX, Smith MB. Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging 2005;21: 192-196.
21. Hoult DI, Lauterbur PC. Sensitivity of the zeugmatographic experiment involving human samples. J Magn Reson 1979;34: 425-433.
22. Hoult DI, Phil D. Sensitivity and power deposition in a high-field imaging experiment. J Magn Reson Imaging 2000;12:46-67.
23. Robitaille PM, Abduljalil AM, Kangarlu A, et al. Human magnetic resonance imaging at 8 T. NMR Biomed 1998;11:263-265.
24. Bitz AK, Kraff O, Orzada S, et al. Assessment of RF safety of transmit coils at 7 Tesla by experimental and numerical procedures. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. (abstract 490).
25. Kraff O, Wrede KH, Schoemberg T, et al. MR safety assessment of potential RF heating from cranial fixation plates at 7 T. Med Phys 2013;40:042302.
26. Sammet CL, Yang X, Wassenaar PA, et al. RF-related heating assessment of extracranial neurosurgical implants at 7T. Magn Reson Imaging 2013;31:1029-1034.
27. van Rijn GA, Mourik JE, Teeuwisse WM, Luyten GP, Webb AG. Magnetic resonance compatibility of intraocular lenses measured at 7 Tesla. Invest Ophthalmol Vis Sci 2012;53:3449-3453.
28. Santoro D, Winter L, Muller A, et al. Detailing radio frequency heating induced by coronary stents: a 7.0 Tesla magnetic resonance study. PLoS One 2012;7:e49963.
29. Ugurbil K, Garwood M, Rath AR, Bendall MR. Amplitude-modulated and frequency phase-modulated refocusing pulses that induce plane rotations even in the presence of inhomogeneous B1 fields. J Magn Reson 1988;78:472-497.
30. Staewen RS, Johnson AJ, Ross BD, Parrish T, Merkle H, Garwood M. 3-D Flash imaging using a single surface coil and a new adiabatic pulse, Bir-4. Invest Radiol 1990;25:559-567.
31. Conolly S, Nishimura D, Macovski A. A selective adiabatic spinecho pulse. J Magn Reson 1989;83:324-334.
32. Park JY, Garwood M. Spin-echo MRI using pi/2 and pi hyperbolic secant pulses. Magn Reson Med 2009;61:175-187.
33. Levitt MH, Freeman R. Compensation for Pulse Imperfections in NMR spin-echo experiments. J Magn Reson 1981;43:65-80.
34. Maas MC, Vos EK, Lagemaat MW, et al. Feasibility of T - weighted turbo spin echo imaging of the human prostate at 7 tesla. Magn Reson Med 2013. [Epub ahead of print].
35. Hargreaves BA, Cunningham CH, Nishimura DG, Conolly SM. Variable-rate selective excitation for rapid MRI sequences. Magn Reson Med 2004;52:590-597.
36. Norris DG, Koopmans PJ, Boyacioglu R, Barth M. Power Independent of Number of Slices (PINS) radiofrequency pulses for low-power simultaneous multislice excitation. Magn Reson Med 2011;66:1234-1240.
37. Yang QX, Mao W, Wang J, et al. Manipulation of image intensity distribution at 7.0 T: passive RF shimming and focusing with dielectric materials. J Magn Reson Imaging 2006;24:197-202.
38. Teeuwisse WM, Brink WM, Haines KN, Webb AG. Simulations of high permittivity materials for 7 T neuroimaging and evaluation of a new barium titanate-based dielectric. Magn Reson Med 2012;67:912-918.
39. Mao W, Smith MB, Collins CM. Exploring the limits of RF shimming for high-field MRI of the human head. Magn Reson Med 2006;56:918-922.
40. van den Bergen B, Van den Berg CA, Bartels LW, Lagendijk JJ. 7 T body MRI: B1 shimming with simultaneous SAR reduction. Phys Med Biol 2007;52:5429-5441.
41. Umutlu L, Bitz AK, Maderwald S, et al. Contrast-enhanced ultra-high-field liver MRI: a feasibility trial. Eur J Radiol 2013; 82:760-767.
42. Orzada S, Maderwald S, Poser BA, Bitz AK, Quick HH, Ladd ME. RF excitation using time interleaved acquisition of modes (TIAMO) to address B1 inhomogeneity in high-field MRI. Magn Reson Med 2010;64:327-333.
43. Orzada S, Maderwald S, Poser BA, et al. Time-interleaved acquisition of modes: an analysis of SAR and image contrast implications. Magn Reson Med 2012;67:1033-1041.
44. Katscher U, Bornert P, Leussler C, van den Brink JS. Transmit SENSE. Magn Reson Med 2003;49:144-150.
45. Zhu Y. Parallel excitation with an array of transmit coils. Magn Reson Med 2004;51:775-784.
46. Cloos MA, Boulant N, Luong M, et al. Parallel-transmissionenabled magnetization-prepared rapid gradient-echo T1-weighted imaging of the human brain at 7 T. Neuroimage 2012;62: 2140-2150.
47. Schneider JT, Kalayciyan R, Haas M, et al. Inner-volume imaging in vivo using three-dimensional parallel spatially selective excitation. Magn Reson Med 2013;69:1367-1378.
48. Katscher U, Bornert P. Parallel RF transmission in MRI. NMR Biomed 2006;19:393-400.
49. Graesslin I, Homann H, Biederer S, et al. A specific absorption rate prediction concept for parallel transmission MR. Magn Reson Med 2012;68:1664-1674.
50. Eichfelder G, Gebhardt M. Local specific absorption rate control for parallel transmission by virtual observation points. Magn Reson Med 2011;66:1468-1476.
51. Homann H, Bornert P, Eggers H, Nehrke K, Dossel O, Graesslin I. Toward individualized SAR models and in vivo validation. Magn Reson Med 2011;66:1767-1776.
52. Voigt T, Homann H, Katscher U, Doessel O. Patient-individual local SAR determination: in vivo measurements and numerical validation. Magn Reson Med 2012;68:1117-1126.
53. Katscher U, Voigt T, Findeklee C, Vernickel P, Nehrke K, Dossel O. Determination of electric conductivity and local SAR via B1 mapping. IEEE Trans Med Imaging 2009;28:1365-1374.
54. Haacke EM, Petropoulos LS, Nilges EW, Wu DH. Extraction of conductivity and permittivity using magnetic-resonance-imaging. Phys Med Biol 1991;36:723-734.
55. van Lier AL, Raaijmakers A, Voigt T, et al. Electrical properties tomography in the human brain at 1.5, 3, and 7T: a comparison study. Magn Reson Med 2014;71:354-363.
56. Kim DH, Choi N, Gho SM, Shin J, Liu C. Simultaneous imaging of in vivo conductivity and susceptibility. Magn Reson Med 2013. [Epub ahead of print].
57. Shrivastava D, Vaughan JT. A generic bioheat transfer thermal model for a perfused tissue. J Biomech Eng 2009;131:074506.
58. Murbach M, Neufeld E, Pruessmann KP, Kuster N. Safe MR scan times based on CEM43 tissue damage thresholds, using electromagnetic and thermal simulations with anatomically correct human models and considering local thermoregulation. In: Proceedings of the 20th Scientific Meeting of ISMRM, Melbourne, Australia, 2012. (abstract 313).
59. Yuh WT, Christoforidis GA, Koch RM, et al. Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-ofthe- art review. Top Magn Reson Imaging 2006;17:53-61.
60. Moenninghoff C, Maderwald S, Theysohn JM, et al. Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results. Eur Radiol 2010;20:704-713.
61. Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility- based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol 2004;25:756-760.
62. Christoforidis GA, Yang M, Abduljalil A, et al. "Tumoral pseudoblush" identified within gliomas at high-spatialresolution ultrahigh-field-strength gradient-echo MR imaging corresponds to microvascularity at stereotactic biopsy. Radiology 2012;264:210-217.
63. Lupo JM, Chuang CF, Chang SM, et al. 7-Tesla susceptibilityweighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys 2012;82:e493-e500.
64. Monninghoff C, Maderwald S, Theysohn JM, et al. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results. Rofo 2010;182:764-772.
65. von Morze C, Xu D, Purcell DD, et al. Intracranial time-of-flight MR angiography at 7T with comparison to 3T. J Magn Reson Imaging 2007;26:900-904.
66. Kang CK, Park CW, Han JY, et al. Imaging and analysis of lenticulostriate arteries using 7.0-Tesla magnetic resonance angiography. Magn Reson Med 2009;61:136-144.
67. Conijn MM, Hendrikse J, Zwanenburg JJ, et al. Perforating arteries originating from the posterior communicating artery: a 7.0-Tesla MRI study. Eur Radiol 2009;19:2986-2992.
68. Heverhagen JT, Bourekas E, Sammet S, Knopp MV, Schmalbrock P. Time-of-flight magnetic resonance angiography at 7 Tesla. Invest Radiol 2008;43:568-573.
69. Kang CK, Park CA, Lee H, et al. Hypertension correlates with lenticulostriate arteries visualized by 7T magnetic resonance angiography. Hypertension 2009;54:1050-1056.
70. Monninghoff C, Maderwald S, Theysohn JM, et al. Evaluation of intracranial aneurysms with 7 T versus 1.5 T time-of-flight MR angiography - initial experience. Rofo 2009;181:16-23.
71. Schmitter S, Bock M, Johst S, Auerbach EJ, Ugurbil K, Van de Moortele PF. Contrast enhancement in TOF cerebral angiography at 7 T using saturation and MT pulses under SAR constraints: impact of VERSE and sparse pulses. Magn Reson Med 2012;68:188-197.
72. Johst S, Wrede KH, Ladd ME, Maderwald S. Time-of-flight magnetic resonance angiography at 7 T using venous saturation pulses with reduced flip angles. Invest Radiol 2012;47:445-450.
73. Maderwald S, Ladd SC, Gizewski ER, et al. To TOF or not to TOF: strategies for non-contrast-enhanced intracranial MRA at 7 T. MAGMA 2008;21:159-167.
74. Umutlu L, Theysohn N, Maderwald S, et al. 7 Tesla MPRAGE imaging of the intracranial arterial vasculature: nonenhanced versus contrast-enhanced. Acad Radiol 2013;20:628-634.
75. van der Kolk AG, Hendrikse J, Brundel M, et al. Multi-sequence whole-brain intracranial vessel wall imaging at 7.0 tesla. Eur Radiol 2013;23:2996-3004.
76. Dammann P, Wrede KH, Maderwald S, et al. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry 2013;84:194-200.
77. Theysohn JM, Kraff O, Maderwald S, et al. The human hippocampus at 7 T-in vivo MRI. Hippocampus 2009;19:1-7.
78. Grams AE, Kraff O, Kalkmann J, et al. Magnetic resonance imaging of cranial nerves at 7 Tesla. Clin Neuroradiol 2013;23: 17-23.
79. Lenglet C, Abosch A, Yacoub E, De Martino F, Sapiro G, Harel N. Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI. PLoS One 2012;7:e29153.
80. Kollia K, Maderwald S, Putzki N, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30: 699-702.
81. Tallantyre EC, Morgan PS, Dixon JE, et al. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 2010;32:971-977.
82. de Graaf WL, Kilsdonk ID, Lopez-Soriano A, et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol 2013;23:528-540.
83. Wattjes MP, Harzheim M, Lutterbey GG, et al. Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol 2008;255:1159-1163.
84. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076-2078.
85. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 2008;65:812-816.
86. Sinnecker T, Bozin I, Dorr J, et al. Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study. Mult Scler 2013;19:316-325.
87. Wuerfel J, Sinnecker T, Ringelstein EB, et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 2012;18:1592-1599.
88. Wood ET, Ronen I, Techawiboonwong A, et al. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci 2012;32:6665-6669.
89. Kraff O, Bitz AK, Kruszona S, et al. An eight-channel phased array RF coil for spine MR imaging at 7 T. Invest Radiol 2009; 44:734-740.
90. Vossen M, Teeuwisse W, Reijnierse M, Collins CM, Smith NB, Webb AG. A radiofrequency coil configuration for imaging the human vertebral column at 7 T. J Magn Reson 2011;208:291-297.
91. Sigmund EE, Suero GA, Hu C, et al. High-resolution human cervical spinal cord imaging at 7 T. NMR Biomed 2012;25:891-899.
92. Grams AE, Kraff O, Umutlu L, et al. MRI of the lumbar spine at 7 Tesla in healthy volunteers and a patient with congenital malformations. Skeletal Radiol 2012;41:509-514.
93. Cohen-Adad J, Zhao W, Keil B, et al. 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis. Muscle Nerve 2013;47:760-762.
94. Cohen-Adad J, Zhao W, Wald LL, Oaklander AL. 7T MRI of spinal cord injury. Neurology 2012;79:2217.
95. Pan JW, Duckrow RB, Gerrard J, et al. 7T MR spectroscopic imaging in the localization of surgical epilepsy. Epilepsia 2013; 54:1668-1678.
96. Emir UE, Tuite PJ, Oz G. Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. PLoS One 2012;7:e30918.
97. Wijtenburg SA, Rowland LM, Edden RA, Barker PB. Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging 2013; 38:460-467.
98. Fischer A, Kraff O, Orzada S, et al. Ultrahigh-field Imaging of the biliary tract at 7 T: initial results of Gd-EOB-DTPAenhanced Magnetic Resonance Cholangiography (MRC) investigative radiology. Invest Radiol 2013. [Epub ahead of print].
99. Umutlu L, Orzada S, Kinner S, et al. Renal imaging at 7 Tesla: preliminary results. Eur Radiol 2011;21:841-849.
100. Umutlu L, Kraff O, Orzada S, et al. Dynamic contrast-enhanced renal MRI at 7 Tesla: preliminary results. Invest Radiol 2011;46: 425-433.
101. Metzger GJ, Auerbach EJ, Akgun C, et al. Dynamically applied B1+ shimming solutions for non-contrast enhanced renal angiography at 7.0 Tesla. Magn Reson Med 2013;69:114-126.
102. Umutlu L, Maderwald S, Kraff O, et al. New look at renal vasculature: 7 tesla nonenhanced T1-weighted FLASH imaging. J Magn Reson Imaging 2012;36:714-721.
103. Fischer A, Maderwald S, Orzada S, et al. Nonenhanced magnetic resonance angiography of the lower extremity vessels at 7 tesla: initial experience. Invest Radiol 2013;48:525-534.
104. Fischer A, Johst S, Orzada S, et al. Initial evaluation of noncontrast- enhanced MRA in patients with peripheral arterial occlusive disease at 7 T. Invest Radiol 2013. [Epub ahead of print].
105. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2838-2847.
106. Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007;72:260-264.
107. Snyder CJ, DelaBarre L, Metzger GJ, et al. Initial results of cardiac imaging at 7 Tesla. Magn Reson Med 2009;61:517-524.
108. von Knobelsdorff-Brenkenhoff F, Tkachenko V, Winter L, et al. Assessment of the right ventricle with cardiovascular magnetic resonance at 7 Tesla. J Cardiovasc Magn Reson 2013;15:23.
109. Frauenrath T, Hezel F, Renz W, et al. Acoustic cardiac triggering: a practical solution for synchronization and gating of cardiovascular magnetic resonance at 7 Tesla. J Cardiovasc Magn Reson 2010;12:67.
110. Hezel F, Thalhammer C, Waiczies S, Schulz-Menger J, Niendorf T. High spatial resolution and temporally resolved T2∗ mapping of normal human myocardium at 7.0 Tesla: an ultrahigh field magnetic resonance feasibility study. PLoS One 2012;7:e52324.
111. van Elderen SG, Versluis MJ, Westenberg JJ, et al. Right coronary MR angiography at 7 T: a direct quantitative and qualitative comparison with 3 T in young healthy volunteers. Radiology 2010;257:254-259.
112. Graessl A, Renz W, Hezel F, et al. Modular 32-channel transceiver coil array for cardiac MRI at 7.0T. Magn Reson Med 2013. [Epub ahead of print].
113. Schmitter S, Delabarre L, Wu X, et al. Cardiac imaging at 7 tesla: single- and two-spoke radiofrequency pulse design with 16- channel parallel excitation. Magn Reson Med 2013;70:1210-1219.
114. Brown R, Storey P, Geppert C, et al. Breast MRI at 7 Tesla with a bilateral coil and T1-weighted acquisition with robust fat suppression: image evaluation and comparison with 3 Tesla. Eur Radiol 2013;23:2969-2978.
115. Korteweg MA, Veldhuis WB, Visser F, et al. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy. Invest Radiol 2011;46:370-376.
116. Krug R, Stehling C, Kelley DA, Majumdar S, Link TM. Imaging of the musculoskeletal system in vivo using ultra-high field magnetic resonance at 7 T. Invest Radiol 2009;44:613-618.
117. Welsch GH, Juras V, Szomolanyi P, et al. Magnetic resonance imaging of the knee at 3 and 7 tesla: a comparison using dedicated multi-channel coils and optimised 2D and 3D protocols. Eur Radiol 2012;22:1852-1859.
118. Welsch GH, Apprich S, Zbyn S, et al. Biochemical (T2, T2∗ and magnetisation transfer ratio) MRI of knee cartilage: feasibility at ultra-high field (7T) compared with high field (3T) strength. Eur Radiol 2011;21:1136-1143.
119. Forsen S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963;39:2892.
120. Krusche-Mandl I, Schmitt B, Zak L, et al. Long-term results 8 years after autologous osteochondral transplantation: 7 T gagCEST and sodium magnetic resonance imaging with morphological and clinical correlation. Osteoarthritis Cartilage 2012;20:357-363.
121. Ellermann J, Goerke U, Morgan P, et al. Simultaneous bilateral hip joint imaging at 7 Tesla using fast transmit B(1) shimming methods and multichannel transmission - a feasibility study. NMR Biomed 2012;25:1202-1208.
122. Theysohn J, Kraff O, Orzada S, et al. Bilateral hip imaging at 7 Tesla using a multi-channel transmit technology: initial results presenting anatomical detail in healthy volunteers and pathological changes in patients with avascular necrosis of the femoral head. Skeletal Radiol 2013;42:1555-1563.
123. Deniz CM, Brown R, Lattanzi R, Alon L, Sodickson DK, Zhu Y. Maximum efficiency radiofrequency shimming: theory and initial application for hip imaging at 7 tesla. Magn Reson Med 2013; 69:1379-1388.
124. Kraff O, Orzada S, Choukri M, et al. 7 Tesla MRI of the shoulder & upper extremities using an 8-channel Tx/Rx coil. In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. (abstract 306).
125. Brown R, Deniz CM, Zhang B, et al. Design and application of combined 8-channel transmit and 10-channel receive arrays and radiofrequency shimming for 7-T shoulder magnetic resonance imaging. Invest Radiol 2014;49:35-47.
126. Kemp GJ, Radda GK. Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q 1994;10:43-63.
127. Lei H, Ugurbil K, Chen W. Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 2003;100:14409-14414.
128. Ulrich M, Wokrina T, Ende G, Lang M, Bachert P. 31P-{1H} echo-planar spectroscopic imaging of the human brain in vivo. Magn Reson Med 2007;57:784-790.
129. Moon RB, Richards JH. Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 1973;248:7276-7278.
130. Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J 2012;279:2610-2623.
131. Qiao H, Zhang X, Zhu XH, Du F, Chen W. In vivo 31P MRS of human brain at high/ultrahigh fields: a quantitative comparison of NMR detection sensitivity and spectral resolution between 4 T and 7 T. Magn Reson Imaging 2006;24:1281-1286.
132. Bogner W, Chmelik M, Schmid AI, Moser E, Trattnig S, Gruber S. Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med 2009;62:574-582.
133. Lei H, Zhu XH, Zhang XL, Ugurbil K, Chen W. In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med 2003;49:199-205.
134. Chmelik M, Kukurova IJ, Gruber S, et al. Fully adiabatic 31P 2D-CSI with reduced chemical shift displacement error at 7 T- GOIA-1D-ISIS/2D-CSI. Magn Reson Med 2013;69:1233-1244.
135. Lu A, Atkinson IC, Zhou XJ, Thulborn KR. PCr/ATP ratio mapping of the human head by simultaneously imaging of multiple spectral peaks with interleaved excitations and flexible twisted projection imaging readout trajectories at 9.4 T. Magn Reson Med 2013;69:538-544.
136. Komoroski RA, Holder JC, Pappas AA, Finkbeiner AE. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia. Magn Reson Med 2011;65:911-913.
137. Kobus T, Bitz AK, van Uden MJ, et al. In vivo 31P MR spectroscopic imaging of the human prostate at 7 T: safety and feasibility. Magn Reson Med 2012;68:1683-1695.
138. Klomp DW, van de Bank BL, Raaijmakers A, et al. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer. NMR Biomed 2011;24:1337-1342.
139. Wijnen JP, van der Kemp WJ, Luttje MP, Korteweg MA, Luijten PR, Klomp DW. Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T. Magn Reson Med 2012;68: 339-348.
140. Robinson JD, Flashner MS. The (Na++K+)-activated ATPase. Enzymatic and transport properties. Biochim Biophys Acta 1979;549:145-176.
141. Madelin G, Regatte RR. Biomedical applications of sodium MRI in vivo. J Magn Reson Imaging 2013;38:511-529.
142. Inglese M, Madelin G, Oesingmann N, et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain 2010;133(Pt 3):847-857.
143. Nagel AM, Bock M, Hartmann C, et al. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radiol 2011;46:539-547.
144. Qian Y, Zhao T, Zheng H, Weimer J, Boada FE. High-resolution sodium imaging of human brain at 7 T. Magn Reson Med 2012; 68:227-233.
145. Trattnig S, Welsch GH, Juras V, et al. 23Na MR imaging at 7 T after knee matrix-associated autologous chondrocyte transplantation preliminary results. Radiology 2010;257:175-184.
146. Juras V, Zbyn S, Pressl C, et al. Sodium MR imaging of Achilles tendinopathy at 7 T: preliminary results. Radiology 2012;262: 199-205.
147. Boada FE, Laverde G, Jungreis C, Nemoto E, Tanase C, Hancu I. Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. Curr Top Dev Biol 2005;70:77-101.
148. Smith KJ. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol 2007; 17:230-242.
149. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-1372.
150. Stobbe R, Beaulieu C. In vivo sodium magnetic resonance imaging of the human brain using soft inversion recovery fluid attenuation. Magn Reson Med 2005;54:1305-1310.
151. Madelin G, Lee JS, Inati S, Jerschow A, Regatte RR. Sodium inversion recovery MRI of the knee joint in vivo at 7T. J Magn Reson 2010;207:42-52.
152. Nagel AM, Amarteifio E, Lehmann-Horn F, et al. 3 Tesla sodium inversion recovery magnetic resonance imaging allows for improved visualization of intracellular sodium content changes in muscular channelopathies. Invest Radiol 2011;46:759-766.
153. Stobbe R, Beaulieu C. Sodium imaging optimization under specific absorption rate constraint. Magn Reson Med 2008;59:345-355.
154. Benkhedah N, Bachert P, Nagel AM. Biexponentially weighted sodium imaging with higher SNR efficiency. In: Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, 2013. (abstract 1992).
155. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-1547.
156. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12- month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64: 543-552.
157. Newman PK, Saunders M. Lithium neurotoxicity. Postgrad Med J 1979;55:701-703.
158. Harris RK, Becker ED, Cabral de Menezes SM, Goodfellow R, Granger P. NMR nomenclature: nuclear spin properties and conventions for chemical shifts. IUPAC Recommendations 2001. International Union of Pure and Applied Chemistry. Physical Chemistry Division. Commission on Molecular Structure and Spectroscopy. Magn Reson Chem 2002;40:489-505.
159. Boada FE, Qian Y, Gildengers A, Phillips M, Kupfer D. In vivo 3D lithiumMRI of the human brain. In; Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010: (abstract 592).
160. Fukuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994;35:1-6.
161. Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 2008;8:81-86.
162. Zhu XH, Zhang N, Zhang Y, Zhang X, Ugurbil K, Chen W. In vivo 17O NMR approaches for brain study at high field. NMR Biomed 2005;18:83-103.
163. Hoffmann SH, Begovatz P, Nagel AM, et al. A measurement setup for direct 17O MRI at 7 T. Magn Reson Med 2011;66: 1109-1115.
164. Atkinson IC, Thulborn KR. Feasibility of mapping the tissue mass corrected bioscale of cerebral metabolic rate of oxygen consumption using 17-oxygen and 23-sodium MR imaging in a human brain at 9.4 T. Neuroimage 2010;51:723-733.
165. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990;113(Pt 1):27-47.
166. Hoffmann SH, Radbruch A, Semmler W, Nagel AM. Partial volume corrected CMRO2 determination in a glioblastoma patient by 17O MRI. In: Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, 2013. (abstract 216).
167. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev 2002;82:503-568.
168. Jurkat-Rott K, Lehmann-Horn F. State of the art in hereditary muscle channelopathies. Acta Myol 2010;29:343-350.
169. Nagel AM, Meise FM, Weber MA, et al. Chlorine (35Cl) magnetic resonance imaging of the human brain and muscle. In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. (abstract 1699).
170. Parrish TB, Fieno DS, Fitzgerald SW, Judd RM. Theoretical basis for sodium and potassium MRI of the human heart at 1.5 T. Magn Reson Med 1997;38:653-661.
171. Augath M, Heiler P, Kirsch S, Schad LR. In vivo 39K, 23Na and 1H MR imaging using a triple resonant RF coil setup. J Magn Reson 2009;200:134-136.
172. Umathum R, Roesler MB, Nagel AM. In vivo potassium (39K) magnetic resonance imaging of human muscle and brain. Radiology 2013;269:569-576.
173. Atkinson IC, Claiborne TC, Thulborn KR. Feasibility of 39- potassium MR imaging of a human brain at 9.4 Tesla. Magn Reson Med 2013. [Epub ahead of print].